Our therapy areas

Unlocking the power of what science can do

The path to new treatments

The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following: Oncology; BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology); and Rare Disease.

   


An exciting pipeline

Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.

183

projects in our pipeline

16

new molecular entities in our late-stage pipeline

2

new molecular entities under review

Veeva ID: Z4-43253
Date of preparation: March 2022